Comparison of Two Soft Bifocal Contact Lenses
1 other identifier
interventional
113
1 country
6
Brief Summary
The purpose of the study is to compare the visual performance of two soft bifocal contact lenses.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2008
Shorter than P25 for not_applicable
6 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 25, 2008
CompletedFirst Posted
Study publicly available on registry
July 30, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2008
CompletedResults Posted
Study results publicly available
January 27, 2010
CompletedMay 21, 2015
May 1, 2015
1 month
July 25, 2008
September 25, 2009
May 5, 2015
Conditions
Outcome Measures
Primary Outcomes (3)
Distance Visual Acuity
This outcome measures vision while subjects are looking at objects in the distance and is measures in logMARs.logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values \>0.00 indicate vision poorer than ideal and values\<0.0 indicate vision greater than ideal
after 1 week of wear
Near Visual Acuity
This outcome measures vision while subjects are looking at objects near to them and is measured in logMARs. logMAR is the logarithm of the minimum angle of resolution.The ideal is 0.0 and represents 20/20 Snellen acuity.logMAR values \>0.00 indicate vision poorer than ideal and values\<0.0 indicate vision greater than ideal.
after 1 week wear
Subject Vision
Subjects responded to "How would you rate the overall quality of vision with these study contact lenses" using the following scale: 1=poor, 2=fair, 3=good, 4=very good, 5=excellent.
after 1 week wear
Study Arms (2)
senofilcon A / balafilcon A
ACTIVE COMPARATORsenofilcon A multifocal lenses worn first, balafilcon A multifocal lenses worn second
balafilcon A/senofilcon A
ACTIVE COMPARATORbalafilcon A multifocal lenses worn first, senofilcon A multifocal lenses worn second
Interventions
Eligibility Criteria
You may qualify if:
- The subject must between 35 and 70 years of age.
- The subject must have presbyopic symptoms or be already wearing presbyopic contact lens correction.
- The subject's spherical equivalent distance refraction must be in the range of -1.00 to -6.00 or -9.00 to -10.00 in each eye.
- Refractive cylinder must be -0.75 D in each eye.
- The subject must have an ADD power of +0.75D to +2.50D in each eye.
- The subject must have best corrected visual acuity of 20/20-3 or better in each eye
- The subject's must have at least 20/30-distance vision OU with the study contact lenses.
- The subject must agree that they are comfortable with their vision prior to being dispensed the study lenses
- The subject must be an adapted soft contact lens wearer in both eyes.
- The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
- The subject must read and sign the STATEMENT OF INFORMED CONSENT and be provided a copy of the form.
You may not qualify if:
- Ocular or systemic allergies or disease that may interfere with contact lens wear.
- Systemic disease, autoimmune disease or use of medication, which may interfere with contact lens wear.
- Clinically significant (grade 3 or 4) corneal edema, corneal vascularization, corneal staining or any other abnormality of the cornea, which may contraindicate contact lens wear
- Clinically significant (grade 3 or 4) tarsal abnormalities that might interfere with contact lens wear.
- Any ocular infection.
- Any corneal distortion resulting from previous hard or rigid gas permeable contact lens wear.
- Pregnancy or lactation
- Any infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
- History of diabetes
- History of binocular vision abnormality or strabismus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (6)
Dr. James Weber & Associates
Jacksonville, Florida, 32205, United States
Ted Brink & Associates
Jacksonville, Florida, 32256, United States
Unknown Facility
Jacksonville, Florida, 32256, United States
Eye Associates of Winter Park
Winter Park, Florida, 32792, United States
Lee Rigel
East Lansing, Michigan, 48823, United States
Timothy R. Poling, OD
Roanoke, Virginia, 24153, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Thomas Karkkainen OD
- Organization
- Vistakon
Publication Agreements
- PI is Sponsor Employee
- No
- Restriction Type
- OTHER
- Restrictive Agreement
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2008
First Posted
July 30, 2008
Study Start
July 1, 2008
Primary Completion
August 1, 2008
Study Completion
August 1, 2008
Last Updated
May 21, 2015
Results First Posted
January 27, 2010
Record last verified: 2015-05